Literature DB >> 18937283

Proteomic profiling reveals the prognostic value of adenomatous polyposis coli-end-binding protein 1 in hepatocellular carcinoma.

Tatsuya Orimo1, Hidenori Ojima, Nobuyoshi Hiraoka, Shigeru Saito, Tomoo Kosuge, Tatsuhiko Kakisaka, Hideki Yokoo, Kazuaki Nakanishi, Toshiya Kamiyama, Satoru Todo, Setsuo Hirohashi, Tadashi Kondo.   

Abstract

UNLABELLED: Histological differentiation is a major pathological parameter associated with poor prognosis in patients with hepatocellular carcinoma (HCC) and the molecular signature underlying HCC differentiation may involve key proteins potentially affecting the malignant characters of HCC. To develop prognostic biomarkers for HCC, we examined the global protein expression profiles of 45 surgically resected tissues, including 27 HCCs with different degree of histological differentiation, 11 adjacent nontumor tissues, and seven normal liver tissues. Unsupervised classification grouped the 45 samples according to their histological classification based on the protein expression profiles created by laser microdissection and two-dimensional difference gel electrophoresis (2D-DIGE). Statistical analysis and mass spectrometry identified 26 proteins with differential expression, of which 14 were functionally linked to c-Myc, AP-1, HIF1A, hepatocyte nuclear factor 4 alpha, or the Ras superfamily (RhoA, CDC42, and Rac1). Among the proteins identified, we focused on APC-binding protein EB1 (EB1) because it was dominantly expressed in poorly differentiated HCCs, which generally correlate with the poor prognosis in patients with HCC. In addition, EB1 is controlled by c-Myc, RhoA, and CDC42, which have all been linked to HCC malignancy. Immunohistochemistry in a further 145 HCC cases revealed that EB1 significantly correlated with the degree of histological differentiation (P < 0.001), and univariate and multivariate analyses indicated that EB1 is an independent prognostic factor for recurrence (hazard ratio, 2.740; 95% confidence interval, 1.771-4.239; P < 0.001) and survival (hazard ratio, 2.256; 95% confidence interval, 1.337-3.807; P = 0.002) of patients with HCC after curative surgery.
CONCLUSION: Proteomic profiling revealed the molecular signature behind the progression of HCC, and the prognostic value of EB1 in HCC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18937283     DOI: 10.1002/hep.22552

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  29 in total

1.  Post-translational modifications regulate assembly of early spindle orientation complex in yeast.

Authors:  Daniela Hüls; Zuzana Storchova; Dierk Niessing
Journal:  J Biol Chem       Date:  2012-03-29       Impact factor: 5.157

2.  Can proteomics lead to the discovery of real biomarkers for HCC?

Authors:  Yasuhiro Kuramitsu
Journal:  World J Hepatol       Date:  2010-02-27

3.  Increased plasma levels of the APC-interacting protein MAPRE1, LRG1, and IGFBP2 preceding a diagnosis of colorectal cancer in women.

Authors:  Jon J Ladd; Tina Busald; Melissa M Johnson; Qing Zhang; Sharon J Pitteri; Hong Wang; Dean E Brenner; Paul D Lampe; Raju Kucherlapati; Ziding Feng; Ross L Prentice; Samir M Hanash
Journal:  Cancer Prev Res (Phila)       Date:  2012-01-25

4.  Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver.

Authors:  Shu-Hao Hsu; Bo Wang; Janaiah Kota; Jianhua Yu; Stefan Costinean; Huban Kutay; Lianbo Yu; Shoumei Bai; Krista La Perle; Raghu R Chivukula; Hsiaoyin Mao; Min Wei; K Reed Clark; Jerry R Mendell; Michael A Caligiuri; Samson T Jacob; Joshua T Mendell; Kalpana Ghoshal
Journal:  J Clin Invest       Date:  2012-07-23       Impact factor: 14.808

5.  Hepatectomy Combined with Diaphragmatic Resection for Hepatocellular Carcinoma with Diaphragmatic Involvement: A Propensity Score-Matched Analysis.

Authors:  Tatsuya Orimo; Toshiya Kamiyama; Kenji Wakayama; Shingo Shimada; Akihisa Nagatsu; Yoh Asahi; Yuzuru Sakamoto; Hirofumi Kamachi; Akinobu Taketomi
Journal:  Ann Surg Oncol       Date:  2020-06-25       Impact factor: 5.344

6.  Integrated hepatic transcriptome and proteome analysis of mice with high-fat diet-induced nonalcoholic fatty liver disease.

Authors:  Irina A Kirpich; Leila N Gobejishvili; Marjorie Bon Homme; Sabine Waigel; Matt Cave; Gavin Arteel; Shirish S Barve; Craig J McClain; Ion V Deaciuc
Journal:  J Nutr Biochem       Date:  2010-03-20       Impact factor: 6.048

7.  End-binding protein 1 (EB1) up-regulation is an early event in colorectal carcinogenesis.

Authors:  Yolanda Stypula-Cyrus; Nikhil N Mutyal; Mart Dela Cruz; Dhananjay P Kunte; Andrew J Radosevich; Ramesh Wali; Hemant K Roy; Vadim Backman
Journal:  FEBS Lett       Date:  2014-02-01       Impact factor: 4.124

8.  Increased SSeCKS expression in rat hepatic stellate cells upon activation in vitro and in vivo.

Authors:  Tiangeng You; Yuanzhi Fan; Qi Li; Yong Gao; Yongkang Yang; Zhongxin Zhao; Congjun Wang
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

9.  Interactome-wide analysis identifies end-binding protein 1 as a crucial component for the speck-like particle formation of activated absence in melanoma 2 (AIM2) inflammasomes.

Authors:  Li-Jie Wang; Chia-Wei Hsu; Chiu-Chin Chen; Ying Liang; Lih-Chyang Chen; David M Ojcius; Ngan-Ming Tsang; Chuen Hsueh; Chih-Ching Wu; Yu-Sun Chang
Journal:  Mol Cell Proteomics       Date:  2012-08-06       Impact factor: 5.911

10.  Proteomic differences between hepatocellular carcinoma and nontumorous liver tissue investigated by a combined gel-based and label-free quantitative proteomics study.

Authors:  Dominik A Megger; Thilo Bracht; Michael Kohl; Maike Ahrens; Wael Naboulsi; Frank Weber; Andreas-Claudius Hoffmann; Christian Stephan; Katja Kuhlmann; Martin Eisenacher; Jörg F Schlaak; Hideo A Baba; Helmut E Meyer; Barbara Sitek
Journal:  Mol Cell Proteomics       Date:  2013-03-05       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.